Продолжая использовать сайт, вы даете свое согласие на работу с этими файлами.
Methyldesorphine
Clinical data | |
---|---|
Other names | 3-Hydroxy-6,N-dimethyl- 4,5-epoxymorphin-6-en |
ATC code |
|
Legal status | |
Legal status |
|
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider |
|
UNII | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.036.474 |
Chemical and physical data | |
Formula | C18H21NO2 |
Molar mass | 283.371 g·mol−1 |
3D model (JSmol) | |
| |
| |
NY (what is this?) (verify) |
Methyldesorphine is an opioid analgesic. First synthesized in Germany in 1940 and patented in the US in 1952, it has a high potential for abuse as with any potent opioid agonist, and is sometimes found along with desomorphine as a component of the home-made opioid mixture known as "Krokodil" used in Russia and the neighboring former Soviet republics. It is approximately 15 times more potent than morphine as an analgesic but if the 6-7 bond is saturated, the β isomer is some 50 times more potent than morphine.
Methyldesorphine is listed as a Schedule I Narcotic controlled substance under the Controlled Substances Act 1970 in the United States with a DEA ACSCN of 9302 and zero annual aggregate manufacturing quota. The free base conversion ratio of the hydrochloride is 0.89.